The Grünenthal Group will acquire rights to all dosage forms of Zomig zolmitriptan for the treatment of migraines and cluster headaches, including Zomig nasal spray, from AstraZeneca for $200 million up front plus up to $102 million in future milestone payments the company said. The deal includes rights to market Zomig in all countries where it is approved except … [Read more...] about Grünenthal acquires global rights to Zomig nasal spray
News
InCarda announces positive Phase 1 results for inhaled flecainide
InCarda Therapeutics has announced that a Phase 1 study of InRhythm inhaled flecainide, which it is developing for the treatment of paroxysmal atrial fibrillation (PAF), met its primary and secondary endpoints, with all doses found to be safe and well tolerated and achieving effective plasma levels within 3 minutes. In 2015, InCarda established an Australian … [Read more...] about InCarda announces positive Phase 1 results for inhaled flecainide
Aptar Pharma to manufacture child-resistant and senior-friendly nasal pumps in US
Aptar Pharma has transferred manufacturing equipment for its Child-Resistant and Senior-Friendly Classic Nasal Pump from a plant in Germany to its facility in Congers, NY, the company said. According to Aptar, its child-resistant pump is used for every major brand of topical nasal decongestant spray marketed in the US. The child-resistant pump was developed in … [Read more...] about Aptar Pharma to manufacture child-resistant and senior-friendly nasal pumps in US
Ascend Therapeutics to co-promote Sprix ketorolac nasal spray
Egalet Corporation has announced that Ascend Therapeutics will begin co-promoting Egalet's Sprix ketorolac tromethamine nasal spray to women's healthcare practitioners in the US in the third quarter of 2017 and will continue for at least two years. Financial terms of the deal were not disclosed. Sprix nasal spray was approved for the short term management of … [Read more...] about Ascend Therapeutics to co-promote Sprix ketorolac nasal spray
Nemera partners with the University of Tours for intranasal drug delivery research
Device company Nemera has announced a partnership with the Research Center for Respiratory Diseases (CEPR) at the University of Tours for investigation of a novel intranasal drug delivery method. Nemera, which was formerly known as Rexam Healthcare Devices, markets the Advancia line of nasal spray pumps. The company recently announced that it would develop … [Read more...] about Nemera partners with the University of Tours for intranasal drug delivery research
Entries for new DDL Emerging Scientist award due by June 30
Anyone wishing to enter the competition for the new DDL Emerging Scientist award should submit their CV and a 1000-word synopsis of their work by June 30, 2017. The winner will present the DDL Emerging Scientist Lecture during DDL 2017 and will receive £1,000 and a commemorative award. Any inhalation scientist who received his or her PhD within the past 15 years … [Read more...] about Entries for new DDL Emerging Scientist award due by June 30
Albertsons to sell Lupin’s InspiraChamber exclusively in US
US grocer Albertsons will begin selling Lupin's InspiraChamber antistatic valved holding chamber exclusively in more than 1,700 pharmacies in 35 US states, Lupin has announced. The InspiraChamber spacer can be used with one of several pediatric face masks, including the SootherMask, which includes an opening for a child's pacifier. Lupin licensed the product from … [Read more...] about Albertsons to sell Lupin’s InspiraChamber exclusively in US
MannKind announces new CEO, Brazilian distribution deal for Afrezza
MannKind Corporation has announced the appointment of Michael Castagna as Chief Executive Officer, effective May 25, 2017. Castagna takes over the role from Matthew Pfeffer, who succeeded Alfred Mann as CEO in January 2016. Pfeffer had also served as CFO, a role that will now be filled on an interim basis by Rose Alinaya, who is currently the company's Senior VP … [Read more...] about MannKind announces new CEO, Brazilian distribution deal for Afrezza
Sunovion gets CRL for SUN-101/eFlow glycopyrrolate inhalation solution
According to Sunovion, the FDA has issued a complete response letter (CRL) for its NDA for SUN-101/eFlow glycopyrrolate inhalation solution for the treatment of COPD. Sunovion submitted the NDA for SUN-101/eFlow in July 2016, and the FDA accepted the application in October 2016, giving a PDUFA date of May 29, 2017. In response to the CRL, Sunovion said that it … [Read more...] about Sunovion gets CRL for SUN-101/eFlow glycopyrrolate inhalation solution
Therapix Biosciences to look for US-based CEO
Elran Haber, CEO of Therapix Biosciences, which is developing intranasal cannabinoid-based drugs, will step down "to pursue other professional opportunities" after the company concludes its search for "a permanent, US based Chief Executive Officer," the company said. Over the past year, the Israeli company has licensed both an intranasal cannabinoid formulation … [Read more...] about Therapix Biosciences to look for US-based CEO